TransMedics Group, Inc. Operating Expenses
TransMedics Group, Inc. (TMDX) reported Operating Expenses of $89.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-04
- TransMedics Group, Inc. operating expenses for the quarter ending 2026-06-30 was $89.46M, a 49.05% increase year-over-year.
- TransMedics Group, Inc. operating expenses for the quarter ending 2026-03-31 was $87.86M, a 44.55% increase year-over-year.
- TransMedics Group, Inc. operating expenses for the quarter ending 2025-12-31 was $72.14M, a 13.84% increase year-over-year.
- TransMedics Group, Inc. operating expenses for the quarter ending 2025-09-30 was $61.27M, a 7.65% increase year-over-year.
- TransMedics Group, Inc. operating expenses for fiscal 2025 was $254.22M, a 13.20% increase from fiscal 2024.
- TransMedics Group, Inc. operating expenses for fiscal 2024 was $224.59M, a 22.84% increase from fiscal 2023.
- TransMedics Group, Inc. operating expenses for fiscal 2023 was $182.82M, a 89.04% increase from fiscal 2022.
- TransMedics Group, Inc. operating expenses for fiscal 2022 was $96.71M, a 59.62% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $89.46M 10-Q · filed 2026-08-04 | $177.33M 10-Q · filed 2026-08-04 | $249.47M derived: sum of 3 quarters · filed 2026-08-04 | $310.74M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $87.86M 10-Q · filed 2026-05-05 | $160.00M derived: sum of 2 quarters · filed 2026-05-05 | $221.28M derived: sum of 3 quarters · filed 2026-05-05 | $281.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $72.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $133.42M derived: sum of 2 quarters · filed 2026-02-24 | $193.44M derived: sum of 3 quarters · filed 2026-08-04 | $254.22M 10-K · filed 2026-02-24 |
| 2025-09-30 | $61.27M 10-Q · filed 2025-10-29 | $121.30M derived: sum of 2 quarters · filed 2026-08-04 | $182.08M 10-Q · filed 2025-10-29 | $245.45M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $60.02M 10-Q · filed 2026-08-04 | $120.81M 10-Q · filed 2026-08-04 | $184.18M derived: sum of 3 quarters · filed 2026-08-04 | $241.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $60.78M 10-Q · filed 2026-05-05 | $124.15M derived: sum of 2 quarters · filed 2026-05-05 | $181.08M derived: sum of 3 quarters · filed 2026-05-05 | $237.83M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $63.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $120.29M derived: sum of 2 quarters · filed 2026-02-24 | $177.04M derived: sum of 3 quarters · filed 2026-02-24 | $224.59M 10-K · filed 2026-02-24 |
| 2024-09-30 | $56.92M 10-Q · filed 2025-10-29 | $113.67M derived: sum of 2 quarters · filed 2025-10-29 | $161.22M 10-Q · filed 2025-10-29 | $206.54M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $56.75M 10-Q · filed 2025-07-30 | $104.29M 10-Q · filed 2025-07-30 | $149.62M derived: sum of 3 quarters · filed 2026-02-24 | $218.61M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $47.54M 10-Q · filed 2025-05-08 | $92.86M derived: sum of 2 quarters · filed 2026-02-24 | $161.86M derived: sum of 3 quarters · filed 2026-02-24 | $199.51M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $45.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $114.32M derived: sum of 2 quarters · filed 2026-02-24 | $151.97M derived: sum of 3 quarters · filed 2026-02-24 | $182.82M 10-K · filed 2026-02-24 |
| 2023-09-30 | $69.00M 10-Q · filed 2024-10-29 | $106.64M derived: sum of 2 quarters · filed 2024-10-29 | $137.50M 10-Q · filed 2024-10-29 | $164.98M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $37.65M 10-Q · filed 2024-08-01 | $68.50M 10-Q · filed 2024-08-01 | $95.98M derived: sum of 3 quarters · filed 2025-02-27 | $119.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $30.86M 10-Q · filed 2024-05-02 | $58.34M derived: sum of 2 quarters · filed 2025-02-27 | $82.00M derived: sum of 3 quarters · filed 2025-02-27 | $106.09M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $27.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $51.14M derived: sum of 2 quarters · filed 2025-02-27 | $75.24M derived: sum of 3 quarters · filed 2025-02-27 | $96.71M 10-K · filed 2025-02-27 |
| 2022-09-30 | $23.66M 10-Q · filed 2023-11-08 | $47.75M derived: sum of 2 quarters · filed 2023-11-08 | $69.23M 10-Q · filed 2023-11-08 | $87.54M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $24.09M 10-Q · filed 2023-08-04 | $45.57M 10-Q · filed 2023-08-04 | $63.88M derived: sum of 3 quarters · filed 2024-02-27 | $79.38M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $21.47M 10-Q · filed 2023-05-04 | $39.79M derived: sum of 2 quarters · filed 2024-02-27 | $55.28M derived: sum of 3 quarters · filed 2024-02-27 | $70.74M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $18.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $33.81M derived: sum of 2 quarters · filed 2024-02-27 | $49.27M derived: sum of 3 quarters · filed 2024-02-27 | $60.59M 10-K · filed 2024-02-27 |
| 2021-09-30 | $15.50M 10-Q · filed 2022-11-04 | $30.95M derived: sum of 2 quarters · filed 2022-11-04 | $42.27M 10-Q · filed 2022-11-04 | $53.00M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $15.46M 10-Q · filed 2022-08-03 | $26.77M 10-Q · filed 2022-08-03 | $37.50M derived: sum of 3 quarters · filed 2023-02-27 | $47.15M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $11.32M 10-Q · filed 2022-05-05 | $22.04M derived: sum of 2 quarters · filed 2023-02-27 | $31.69M derived: sum of 3 quarters · filed 2023-02-27 | $41.46M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $10.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $20.37M derived: sum of 2 quarters · filed 2023-02-27 | $30.14M derived: sum of 3 quarters · filed 2023-02-27 | $43.02M 10-K · filed 2021-03-11 |
| 2020-09-30 | $9.65M 10-Q · filed 2021-11-09 | $19.42M derived: sum of 2 quarters · filed 2021-11-09 | $32.30M 10-Q · filed 2021-11-09 | $44.73M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $9.77M 10-Q · filed 2021-08-06 | $22.65M 10-Q · filed 2021-08-06 | $35.08M derived: sum of 3 quarters · filed 2021-08-06 | $46.54M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $12.88M 10-Q · filed 2021-05-07 | $25.31M derived: sum of 2 quarters · filed 2021-05-07 | $36.77M derived: sum of 3 quarters · filed 2021-05-07 | $47.81M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $12.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $23.89M derived: sum of 2 quarters · filed 2021-03-11 | $34.93M derived: sum of 3 quarters · filed 2021-03-11 | $43.47M 10-K · filed 2021-03-11 |
| 2019-09-28 | $11.46M 10-Q · filed 2020-11-06 | $22.50M derived: sum of 2 quarters · filed 2020-11-06 | $31.03M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $11.04M 10-Q · filed 2020-08-07 | $19.57M 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $8.54M 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $25.97M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $6.07M 10-Q · filed 2019-11-08 | $12.41M derived: sum of 2 quarters · filed 2019-11-08 | $18.11M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $6.33M 10-Q · filed 2019-08-08 | $12.04M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $5.71M 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |